Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02107365
Brief Title: Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)

First Submitted : March 31, 2014
First Submitted that Met QC Criteria : April 3, 2014
First Posted : April 8, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 23, 2017
Last Update Posted : January 24, 2017 (Estimate)